20. Inventories
The following table provides an overview of our inventories by type of inventory:
|
December 31 |
|
|---|---|---|
(thousands of €) |
2025 |
2024 |
Raw materials |
22,493 |
51,192 |
Total inventories |
22,493 |
51,192 |
Our inventory consisted in full out of Jyseleca® products that is gradually sold to Alfasigma until depletion following the sale of the Jyseleca® business on January 31, 2024.
Jyseleca®
Brand name for filgotinib